FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for patients with metastatic or locally advanced esophageal or gastroesophageal carcinoma
FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) in combination with platinum and fluoropyrimidine-based chemotherapy for patients with metastatic or locally advanced esophageal or gastroesophageal carcinoma. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Esophageal Cancer: An Updated Review Esophageal Cancer: An Updated Review
The incidence of esophageal cancer is on the rise. Review its epidemiology, risk factors, diagnosis and management in this update.Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
Mayo Clinic Q & amp;A podcast: Esophageal cancer is one of the deadliest cancers
Esophageal cancer occurs in the esophagus -- a long, hollow tube that runs from the throat to the stomach -- and can occur anywhere along the esophagus. Men are more likely to develop esophageal cancer than women. While treatable, esophageal cancer is rarely curable. "It's an uncommon cancer," says Dr. Shanda Blackmon, a Mayo Clinic general thoracic surgeon. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 5, 2021 Category: Databases & Libraries Source Type: news
Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer
Disease - free survival significantly longer in patients with resected esophageal, gastroesophageal junction cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 1, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Journal, Source Type: news
Drug Could Be a ‘ Game - Changer ’ in Fighting Esophageal Cancers
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 1, 2021 Category: Cancer & Oncology Tags: Oncology, Pharmacy, News, Source Type: news
Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer
THURSDAY, April 1, 2021 -- Among patients with resected esophageal or gastroesophageal junction cancer who have received neoadjuvant chemoradiotherapy, disease-free survival is significantly longer with nivolumab adjuvant therapy versus placebo,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2021 Category: Pharmaceuticals Source Type: news
Drug Could Be a'Game-Changer' in Fighting Esophageal Cancers
THURSDAY, April 1, 2021 -- Patients who have surgery for esophageal cancer commonly see the disease return, but a drug that boosts the immune system may help delay or prevent that, a new trial has found.
The drug, called Opdivo (nivolumab), doubled... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 1, 2021 Category: General Medicine Source Type: news
Drug Could Be a'Game-Changer' in Fighting Esophageal Cancers
Title: Drug Could Be a ' Game-Changer ' in Fighting Esophageal CancersCategory: Health NewsCreated: 4/1/2021 12:00:00 AMLast Editorial Review: 4/1/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 1, 2021 Category: Cancer & Oncology Source Type: news
Discontinuing chemotherapy for oesophageal cancer cost effective?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2021 Category: Drugs & Pharmacology Source Type: news
A ‘Game Changer’ for Patients With Esophageal Cancer
A drug that unleashes the immune system offers a rare glimmer of hope for those with a cancer that resists most treatments. (Source: NYT Health)
Source: NYT Health - March 31, 2021 Category: Consumer Health News Authors: Gina Kolata Tags: Clinical Trials Esophageal Cancer Drugs (Pharmaceuticals) Chemotherapy Radiation Alcoholic Beverages Bristol Myers Squibb Company New England Journal of Medicine East Asia United States Source Type: news
Procedures identify Barrett's esophagus patients at risk for cancer progression
(Johns Hopkins Medicine) A combination of esophageal brushing and extensive genetic sequencing of the sample collected can detect chromosome alterations in people with Barrett's Esophagus, identifying patients at risk for progressing to esophageal cancer, according to a new study by researchers at the Johns Hopkins Kimmel Cancer Center and Case Western Reserve University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2021 Category: International Medicine & Public Health Source Type: news
FDA Approves Merck ’s Keytruda (pembrolizumab) Plus Platinum- and Fluoropyrimidine-Based Chemotherapy for Treatment of Certain Patients With Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction (GEJ) Carcinoma
KENILWORTH, N.J.--(BUSINESS WIRE) March 23, 2021 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 23, 2021 Category: Drugs & Pharmacology Source Type: news
Electronic 'nose' that detects chemicals in breath may help spot early signs of oesophageal tumour
The breathalyser-type device uses sensors to identify patterns of compounds found in breath that are unique to Barrett's oesophagus, a 'pre' condition to the cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2021 Category: Consumer Health News Source Type: news
FDA approves pembrolizumab for esophageal or GEJ carcinoma
FDA approved pembrolizumab (Keytruda, Merck Sharp& Dohme Corp.) in combination with platinum and fluoropyrimidine-based chemotherapy for patients with metastatic or locally advanced esophageal or gastroesophageal carcinoma who are not candidates for surgical resection or definitive chemoradiation. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 22, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
New Barrett's esophagus monitoring method could aid in easier and more precise prognoses
(Case Western Reserve University) Researchers find that a single esophageal brushing, combined with massively parallel sequencing, can identify Barrett's esophagus patients with disease progression to precancerous cells or carcinoma (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 22, 2021 Category: International Medicine & Public Health Source Type: news
